Architect™ is a stabilized extracellular matrix (ECM) for long-lasting treatment of diabetic foot ulcers, venous leg ulcers and other chronic wounds.
• Does not stimulate excessive proteolytic enzymes in complex wounds
• Helps restore MMP balance and native growth factors
• Stabilized collagen enables reliable fixation to the wound margins
• Provides uninterrupted support of cell migration and regeneration of native extracellular matrix
• Sterile with complete assurance of no viral or bacterial transmission
• No refrigeration or special preparation required
Architect™ is indicated for the treatment of partial- and full-thickness skin wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers.
Contraindicated in patients with known sensitivity to equine-derived materials or with active infection.
Do not re-sterilize. Single use only.
Potential complications include infection, allergic reaction, and chronic inflammatory response.
Store at room temperature.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for second-degree burns|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Rinse and rehydrate prior to use. When applied to the wound and secured with sutures, staples, or tape, keep Architect™ in contact with the wound bed and hydrated.
Architect™ does not require removal or change.
After applying Architect™, a suitable hydrating dressing and a non-adherent secondary dressing should be used.
Stabilized extracellular matrix derived from equine pericardium.
Harbor MedTech, Inc. is a diversified, fully integrated, and global company manufacturing durable and cost-effective bioactive products for treating chronic skin wounds and for reinforcing damaged soft tissue.